Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.960
+0.060 (3.16%)
At close: Nov 7, 2025, 4:00 PM EST
2.000
+0.040 (2.04%)
After-hours: Nov 7, 2025, 7:58 PM EST
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $70.46 million as of November 7, 2025. Its market cap has increased by 2.58% in one year.
Market Cap
70.46M
Enterprise Value
64.45M
1-Year Change
2.58%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $70.46M, a decrease of -43.47%. That is a compound annual growth rate of -11.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 68.30M | 19.21% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | 124.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |